Health product recall

Natesto Gel (2019-08-07)

Starting date:
August 7, 2019
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-70689



Last updated: 2019-08-13

Summary

  • Product:
    Natesto Gel

Reason

The assay is out of specification in the affected lots.

Depth of distribution

Retailers

Affected products

Natesto Gel

DIN, NPN, DIN-HIM

DIN 02450550

Dosage form

Gel

Strength

Testosterone 4.5% / w/w

Lot or serial number

8K8358, 8L8616

Companies

Recalling Firm

Acerus Pharmaceuticals Corporation

2486 Dunwin Dr.

Mississauga

L5L 1J9

Ontario

CANADA

Marketing Authorization Holder

Acerus Pharmaceuticals Corporation

2486 Dunwin Dr.

Mississauga

L5L 1J9

Ontario

CANADA